Cabaletta Bio (CABA) Capital Leases (2024 - 2025)
Cabaletta Bio (CABA) recorded quarterly Capital Leases of $2.9 million in Q4 2025, down 36.84% quarter-over-quarter from $4.6 million in Q3 2025, and down 11.17% on a YoY basis from $3.2 million in Q4 2024.
Cabaletta Bio (CABA) Capital Leases (2024 - 2025) Analysis & Trends
Cabaletta Bio's Capital Leases history runs 2 years deep, the most recent figure standing at $2.9 million for Q4 2025.
- In Q4 2025, Capital Leases fell 11.17% year-over-year to $2.9 million; the TTM figure through Dec 2025 stood at $2.9 million (down 11.17% YoY), while the FY2025 annual figure was $2.9 million, down 11.17% from the prior year.
- Capital Leases was $2.9 million for Q4 2025 at Cabaletta Bio, down from $4.6 million in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $8.1 million in Q1 2025 to a low of $2.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Cabaletta Bio | 151.84 Mn | 18.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.88 Mn |
| Sep 30, 2025 | 4.56 Mn |
| Jun 30, 2025 | 3.90 Mn |
| Mar 31, 2025 | 8.11 Mn |
| Dec 31, 2024 | 3.24 Mn |